Champions肿瘤 CSBR 深 沪
等待开盘 10-02 09:30:00 美东时间
6.40
-0.075
-1.16%
华盛通- 最 高6.60
- 今 开6.50
- 成交量 2.94万股
- 最 低 6.3323
- 昨 收 6.475
- 总市值 8824.58万
- 52周最高 11.99
- 市盈率 静 19.42
- 换手率 0.21%
- 52周最低 3.75
- 委 比 89.83%
- 总股本 1378.84万
- 历史最高 19.80
- 量 比 2.11
- 振 幅 4.13%
- 历史最低 1.11
- 每 手 1
- 风险率 2.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Champions Oncology Reports Steady Revenue and New Leadership
Champions Oncology ( ($CSBR) ) has released its Q1 earnings. Here is a breakdow...
09-16 11:52
Champions Oncology Q1 Adj. EPS $0.02 Beats $(0.01) Estimate, Sales $13.995M Beat $13.513M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.01) by 300 percent. This is a 81.82 percent decrease over earnings of $0.11 per share from
09-16 03:56
Earnings Scheduled For September 15, 2025
Companies Reporting Before The Bell • Coda Octopus Group (NASDAQ:CODA) is proje...
09-15 16:32
Insights Ahead: Champions Oncology's Quarterly Earnings
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings r...
09-12 22:01
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
09-03 18:21
Champions Oncology shares are trading lower. The company reported Q4 financial results.
Champions Oncology shares are trading lower. The company reported Q4 financial ...
07-25 01:21
Champions Oncology Achieves Record Revenue and Profitability
Champions Oncology ( ($CSBR) ) has released its Q4 earnings. Here is a breakdow...
07-24 11:55
Earnings Scheduled For July 23, 2025
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to repor...
07-23 16:32
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
Derek Maetzold, founder and CEO of Castle Biosciences, was awarded the Gold-level Stevie® Lifetime Achievement Award for transformative leadership in healthcare, particularly in molecular diagnostics and precision medicine. The award recognizes his vision, scientific expertise, and commitment to improving patient care. Under his leadership, Castle Biosciences has grown into a industry leader, fundamentally changing clinical care. Judges highlight...
06-04 11:00
